Diabetes mellitus is a condition in which the amount of glucose in the blood is too high because the body cannot use it properly. There are two types of diabetes; Type 1 and Type 2. The most common of the two types is Type 2 diabetes and its accounts for around 90 per cent of people with diabetes in the United Kingdom. The market of Insulin Pen, Insulin Pump, Continuous Glucose Monitoring (CGM) Device and Self Monitoring Blood Glucose Device are growing due to the rising awareness for diabetes in the United Kingdom. United Kingdom Diabetes Market is expected to reach USD 4.33 Billion by the year 2025.


In the United Kingdom, there are more than a million people diagnosed with diabetes, and the number continues to grow. Diabetes is one of the biggest health challenges the United Kingdom is facing today. Growing health crisis and its complications will increase awareness of the risks, improve self-management among people with diabetes bring about wholesale changes in lifestyle and improve access to integrated diabetes care services.


The National Service Framework (NSF) program is improving services by setting national standards to drive up service quality and tackle variations in care. In 2019, The Association of British HealthTech Industries (ABHI) had launched a diabetes section, enabling diabetes technology companies to work together in the first forum of its kind. ABHI group is for any health technology company with an interest in diabetes care from CGM and insulin pumps to apps.


Renub Research report titled "United Kingdom Diabetes Market & Forecast, By Self Monitoring Blood Glucose Device Analysis (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement) Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Insulin Pen Types (Disposable, Reusable & Smart Insulin Pen, Needle Market, Reimbursement Policies), Insulin Pump Market, (User and Reimbursement) Companies (Insulet Corporation, B. Braun Melsungen AG, LifeScan Inc., Artsana S.p.A, BD, Novo Nordisk A/S, Owen Mumford Ltd, Ypsomed AG, Medtronic, Eli Lilly and Company, Abbott Laboratories, Dexcom Inc and Roche)” provides a complete analysis of United Kingdom Insulin Devices Market


Segments Market based on Devices

1. Continuous Glucose Monitoring (CGM)
2. Self Monitoring Blood Glucose (SMBG)
3. Insulin Pen
4. Insulin Pump


United Kingdom Diabetes Sub-Segment Analysis

1. Continuous Glucose Monitoring (CGM)

1. Glucose Sensor Market & Forecast
2. CGM Transmitter Market & Forecast
3. CGM User
4. CGM Reimbursement


2. Self Monitoring Blood Glucose (SMBG)

1. Test Strips Market and Forecast
2. Lancet Market and Forecast
3. Meter Market and Forecast
4. Blood Glucose (SMBG) Users
5. Blood Glucose Devices Reimbursement


3. Insulin Pen

1. Disposable Insulin Pen
2. Reusable Insulin Pen
3. Smart Insulin Pen
4. Insulin Pen Needle Market
5. Insulin Pen Users
6. Reimbursement Policies


4. Insulin Pump


1. Insulin Pump Market
2. Insulin Pump Users
3. Reimbursement Policies


All the 14 Companies Studied in the Report have been Studied from 3 Points

  • Company Overview
  • Recent Developments
  • Financial Insight




Company Analysis

1. B. Braun Melsungen AG
2. Eli Lilly and Company
3. Artsana S.p.A
4. BD
5. Novo Nordisk A/S
6. Owen Mumford Ltd
7. Ypsomed AG
8. Medtronic
9. Insulet Corporation
10. LifeScan Inc.
11. Abbott Laboratories
12. Roche
13. Dexcom Inc